Press Releases & Statements

Investor Relations

Month Year

Month Year

Novavax Initiates Pediatric Expansion for Phase 3 Clinical Trial of COVID-19 Vaccine

May 3, 2021
Novavax to Host Conference Call to Discuss First Quarter Financial Results and Operational Highlights on May 10, 2021

Apr 23, 2021
Malaria Vaccine Phase 2b Clinical Trial Results Published in Preprints with The Lancet
- Matrix-M™ Adjuvant
Apr 23, 2021
Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations
- COVID-19
Apr 14, 2021
Novavax Announces Leadership Updates
- Corporate and Finance
Apr 13, 2021
Novavax to Participate in Fireside Chat at Goldman Sachs Virtual Conference
- Corporate and Finance
Apr 8, 2021
Novavax CEO Stan Erck to Participate in Longwood Healthcare Leaders Meeting
- Corporate and Finance
Apr 5, 2021
Novavax Initiates COVID-19 Vaccine Clinical Trial Crossover
- COVID-19
Apr 5, 2021
GSK to support manufacture of Novavax' COVID-19 vaccine
- COVID-19
Mar 29, 2021
Novavax Confirms High Levels of Efficacy Against Original and Variant COVID-19 Strains in United Kingdom and South Africa Trials
- COVID-19
Mar 11, 2021

Show per page